SPIRIT HEALTH ANNOUNCES NEW MARKET ACCESS SERVICE - SPIRIT ACCESS
SPIRIT HEALTH GROUP ANNOUNCES NEW MARKET ACCESS CONSULTANCY SERVICE - SPIRIT ACCESS - FOR PHARMACEUTICAL, DEVICE INDUSTRY AND NHS CLIENTS
Spirit Health Group has acquired Pathway Communications, to expand the Spirit offer to include healthcare analytics, patient pathway simulation and implementation services to help NHS gain maximum value from Pharmaceutical innovation
Spirit Health Group today announces its new market access consultancy service, Spirit Access, following the acquisition of a majority stake in patient pathway and healthcare development experts, Pathway Communications.
As part of the Spirit Health Group, Spirit Access will combine Pathway Communications’ knowledge of the pharmaceutical and medical technology market with Spirit Healthcare’s resources and expertise in delivering healthcare services to the NHS to help pharma companies show the total value of their offering to the NHS. Spirit Access will provide data analysis, simulation and modelling, implementation and digital solutions to its pharmaceutical and NHS customers.
David Southern, Managing Director, Pathway Communications, who becomes Spirit Access’ Managing Director, comments: “We have worked closely with Spirit over a number of years and there is a strong synergy between the companies that, combined, becomes stronger than the two halves.
“Spirit has an extensive background in working with NHS organisations, including CCGs and Primary Care providers, but has a range of products that offer complementary ways for the NHS to unlock further value from pharmaceutical and medical device products. Likewise, Pathway Communications has a strong track record of working with pharma and wanted to forge a relationship with an organisation which could deliver an implementation model to help the NHS achieve the much needed cost savings and patient benefit outcomes.”
Pathway Communications has developed a number of patient pathway simulations for a range of disease areas – including ophthalmology, COPD, diabetes and cancer - that allow the impact of making change to be readily understood. Delivered to NHS customers through Spirit’s proven implementation model, Spirit Access aims to ensure the highest quality patient outcomes whilst optimising value from medicines budgets.
Chris Barker, CEO, Spirit Health Group, adds: “The challenges of healthcare delivery are many, with local variation, an ageing population, complicated pathways and ever-changing demands and expectations on services. Addressing each challenge requires experience and knowledge in the NHS, an understanding of the pathway and a clear outcome to deliver from each piece of work. We know from experience that there are tangible benefits – both in terms of patient outcomes and NHS financial efficiencies – being achieved today through collaborative approaches to healthcare delivery.
“Spirit Access’ aim is to use our digital technology, implementation services and pathway experience to work with pharmaceutical & medical technology companies to add value for the NHS, Industry and most importantly Patients.”